The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models

Candida Deves, Thiago Milech de Assunção, Rodrigo G. Ducati, Maria Martha Campos, Luiz Augusto Basso, Diogenes Santiago Santos, Eraldo L. Batista

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purine nucleoside phosphorylase (PNP) is a purine-metabolizing enzyme that catalyzes the reversible phosphorolysis of 6-oxypurine (deoxy)nucleosides to their respective bases and (deoxy)ribose-1-phosphate. It is a key enzyme in the purine salvage pathway of mammalian cells. The present investigation sought to determine whether the PNP transition state analog inhibitor (Immucillin-H) arrests bone loss in two models of induced periodontal disease in rats. Periodontal disease was induced in rats using ligature or LPS injection followed by administration of Immucillin-H for direct analysis of bone loss, histology and TRAP staining. In vitro osteoclast differentiation and activation of T CD4. + cells in the presence of Immucillin-H were carried out for assessment of RANKL expression, PNP and Cathepsin K activity. Immucillin-H inhibited bone loss induced by ligatures and LPS, leading to a reduced number of infiltrating osteoclasts and inflammatory cells. In vitro assays revealed that Immucillin-H could not directly abrogate differentiation of osteoclast precursor cells, but affected lymphocyte-mediated osteoclastogenesis. On the other hand, incubation of pre-activated T CD4. + with Immucillin-H decreased RANKL secretion with no compromise of cell viability. The PNP transition state analog Immucillin-H arrests bone loss mediated by T CD4. + cells with no direct effect on osteoclasts. PNP inhibitor may have an impact in the treatment of diseases characterized by the presence of pathogens and imbalances of bone metabolism.

Original languageEnglish (US)
Pages (from-to)167-175
Number of pages9
JournalBone
Volume52
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Purine-Nucleoside Phosphorylase
Periodontal Diseases
Bone and Bones
Osteoclasts
Ligation
Cathepsin K
Enzymes
forodesine
Nucleosides
Osteogenesis
Cell Survival
Histology
Lymphocytes
Staining and Labeling
Injections

Keywords

  • Animal models
  • Bone loss
  • Osteoclasts
  • Periodontal disease
  • Purine nucleoside phophorylase
  • T-lymphocyte

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Cite this

The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models. / Deves, Candida; de Assunção, Thiago Milech; Ducati, Rodrigo G.; Campos, Maria Martha; Basso, Luiz Augusto; Santos, Diogenes Santiago; Batista, Eraldo L.

In: Bone, Vol. 52, No. 1, 01.2013, p. 167-175.

Research output: Contribution to journalArticle

Deves, Candida ; de Assunção, Thiago Milech ; Ducati, Rodrigo G. ; Campos, Maria Martha ; Basso, Luiz Augusto ; Santos, Diogenes Santiago ; Batista, Eraldo L. / The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models. In: Bone. 2013 ; Vol. 52, No. 1. pp. 167-175.
@article{4ce70d014aec4b9ba38e4e5ca6857ec4,
title = "The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models",
abstract = "Purine nucleoside phosphorylase (PNP) is a purine-metabolizing enzyme that catalyzes the reversible phosphorolysis of 6-oxypurine (deoxy)nucleosides to their respective bases and (deoxy)ribose-1-phosphate. It is a key enzyme in the purine salvage pathway of mammalian cells. The present investigation sought to determine whether the PNP transition state analog inhibitor (Immucillin-H) arrests bone loss in two models of induced periodontal disease in rats. Periodontal disease was induced in rats using ligature or LPS injection followed by administration of Immucillin-H for direct analysis of bone loss, histology and TRAP staining. In vitro osteoclast differentiation and activation of T CD4. + cells in the presence of Immucillin-H were carried out for assessment of RANKL expression, PNP and Cathepsin K activity. Immucillin-H inhibited bone loss induced by ligatures and LPS, leading to a reduced number of infiltrating osteoclasts and inflammatory cells. In vitro assays revealed that Immucillin-H could not directly abrogate differentiation of osteoclast precursor cells, but affected lymphocyte-mediated osteoclastogenesis. On the other hand, incubation of pre-activated T CD4. + with Immucillin-H decreased RANKL secretion with no compromise of cell viability. The PNP transition state analog Immucillin-H arrests bone loss mediated by T CD4. + cells with no direct effect on osteoclasts. PNP inhibitor may have an impact in the treatment of diseases characterized by the presence of pathogens and imbalances of bone metabolism.",
keywords = "Animal models, Bone loss, Osteoclasts, Periodontal disease, Purine nucleoside phophorylase, T-lymphocyte",
author = "Candida Deves and {de Assun{\cc}{\~a}o}, {Thiago Milech} and Ducati, {Rodrigo G.} and Campos, {Maria Martha} and Basso, {Luiz Augusto} and Santos, {Diogenes Santiago} and Batista, {Eraldo L.}",
year = "2013",
month = "1",
doi = "10.1016/j.bone.2012.09.026",
language = "English (US)",
volume = "52",
pages = "167--175",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The transition state analog inhibitor of Purine Nucleoside Phosphorylase (PNP) Immucillin-H arrests bone loss in rat periodontal disease models

AU - Deves, Candida

AU - de Assunção, Thiago Milech

AU - Ducati, Rodrigo G.

AU - Campos, Maria Martha

AU - Basso, Luiz Augusto

AU - Santos, Diogenes Santiago

AU - Batista, Eraldo L.

PY - 2013/1

Y1 - 2013/1

N2 - Purine nucleoside phosphorylase (PNP) is a purine-metabolizing enzyme that catalyzes the reversible phosphorolysis of 6-oxypurine (deoxy)nucleosides to their respective bases and (deoxy)ribose-1-phosphate. It is a key enzyme in the purine salvage pathway of mammalian cells. The present investigation sought to determine whether the PNP transition state analog inhibitor (Immucillin-H) arrests bone loss in two models of induced periodontal disease in rats. Periodontal disease was induced in rats using ligature or LPS injection followed by administration of Immucillin-H for direct analysis of bone loss, histology and TRAP staining. In vitro osteoclast differentiation and activation of T CD4. + cells in the presence of Immucillin-H were carried out for assessment of RANKL expression, PNP and Cathepsin K activity. Immucillin-H inhibited bone loss induced by ligatures and LPS, leading to a reduced number of infiltrating osteoclasts and inflammatory cells. In vitro assays revealed that Immucillin-H could not directly abrogate differentiation of osteoclast precursor cells, but affected lymphocyte-mediated osteoclastogenesis. On the other hand, incubation of pre-activated T CD4. + with Immucillin-H decreased RANKL secretion with no compromise of cell viability. The PNP transition state analog Immucillin-H arrests bone loss mediated by T CD4. + cells with no direct effect on osteoclasts. PNP inhibitor may have an impact in the treatment of diseases characterized by the presence of pathogens and imbalances of bone metabolism.

AB - Purine nucleoside phosphorylase (PNP) is a purine-metabolizing enzyme that catalyzes the reversible phosphorolysis of 6-oxypurine (deoxy)nucleosides to their respective bases and (deoxy)ribose-1-phosphate. It is a key enzyme in the purine salvage pathway of mammalian cells. The present investigation sought to determine whether the PNP transition state analog inhibitor (Immucillin-H) arrests bone loss in two models of induced periodontal disease in rats. Periodontal disease was induced in rats using ligature or LPS injection followed by administration of Immucillin-H for direct analysis of bone loss, histology and TRAP staining. In vitro osteoclast differentiation and activation of T CD4. + cells in the presence of Immucillin-H were carried out for assessment of RANKL expression, PNP and Cathepsin K activity. Immucillin-H inhibited bone loss induced by ligatures and LPS, leading to a reduced number of infiltrating osteoclasts and inflammatory cells. In vitro assays revealed that Immucillin-H could not directly abrogate differentiation of osteoclast precursor cells, but affected lymphocyte-mediated osteoclastogenesis. On the other hand, incubation of pre-activated T CD4. + with Immucillin-H decreased RANKL secretion with no compromise of cell viability. The PNP transition state analog Immucillin-H arrests bone loss mediated by T CD4. + cells with no direct effect on osteoclasts. PNP inhibitor may have an impact in the treatment of diseases characterized by the presence of pathogens and imbalances of bone metabolism.

KW - Animal models

KW - Bone loss

KW - Osteoclasts

KW - Periodontal disease

KW - Purine nucleoside phophorylase

KW - T-lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=84867593849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867593849&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2012.09.026

DO - 10.1016/j.bone.2012.09.026

M3 - Article

VL - 52

SP - 167

EP - 175

JO - Bone

JF - Bone

SN - 8756-3282

IS - 1

ER -